Search Results
Jun 09, 2026, 09:00 ET Agrochemical Giants Face Explosive Paraquat Parkinson's Disease Allegations as Wisner Baum Trial Date is Set in California
Bhudhikanok, G. S., Kasten, M., Chade, A. R., Comyns, K., Richards, M. B., Meng, C., Priestley, B., Fernandez, H. H., Cambi, F., Umbach, D. M., Blair, A., Sandler, D. P., & Langston, J. W. (2011). Rotenone, paraquat, and Parkinson's disease. Environmental Health Perspectives, 119(6), 866–872. Media
More news about: Wisner Baum
Jun 09, 2026, 09:00 ET Estudo que acaba de ser publicado, no maior congresso de reumatologia da Europa, demonstra eficácia superior de nova molécula no tratamento da artrite psoriásica já na 16ª semana
graves, especialmente nas áreas de neurologia e imunologia. A UCB investe aproximadamente 25% do faturamento global em pesquisa e desenvolvimento (P&D) voltada a soluções inovadoras que geram valor real na vida dos pacientes, afinal, seu propósito é garantir que todos possam viver da melhor forma
More news about: UCB Biopharma
Jun 09, 2026, 09:00 ET NINJIO Releases 2026 Core Four Cybersecurity Awareness Fundamentals Course to Address Emerging Threats
engineering to sharpen users' intuition. The proprietary NINJIO Risk Algorithm™ identifies users' social engineering vulnerabilities based on NINJIO PHISH3D phishing simulation data and informs content delivery to provide a personalized experience that changes individual behavior. For more information:
More news about: NINJIO
Jun 09, 2026, 09:00 ET Formation Bio Doses First Participant in Phase 1 Trial of BLKR201, a CNS-Penetrant TYK2 Inhibitor
innovation, developing differentiated small-molecule therapies, and providing superior oral alternatives to biologics. The company was founded by senior R&D leaders from Pfizer, MSD, and Johnson & Johnson, focusing on the JAK-STAT and expanding to TYK2 signaling pathways, and mastering targeted protein
More news about: Formation Bio
Jun 09, 2026, 09:00 ET Broadcom, Apollo, and Blackstone Establish Landmark Strategic Platform to Accelerate More Than 20 Gigawatts of Global AI Deployments
develops, and supplies semiconductors and infrastructure software for global organizations' complex, mission-critical needs. Broadcom combines long-term R&D investment with superb execution to deliver the best technology, at scale. Broadcom is a Delaware corporation headquartered in Palo Alto, CA. For more
More news about: Broadcom Inc.
Jun 09, 2026, 08:59 ET CRRC 주저우 연구소, 스마터 E 유럽 2026에서 6.X 액체 냉각 에너지 저장 시스템 선보여
multimedia:https://www.prnewswire.com/kr/news-releases/u0063u0072u0072u0063u002DuC8FCuC800uC6B0u002DuC5F0uAD6CuC18Cu002Cu002DuC2A4uB9C8uD130u002Du0065u002DuC720uB7FDu002Du0032u0030u0032u0036uC5D0-302795291.htmlSOURCE
More news about: CRRC Zhuzhou Institute
Jun 09, 2026, 08:54 ET 안타이솔라, SNEC 2026서 업그레이드된 2P 트래커 솔루션 선보이며 글로벌 파트너십 여러 건 체결
content:https://www.prnewswire.com/kr/news-releases/uC548uD0C0uC774uC194uB77Cu002Cu002Du0073u006Eu0065u0063u002Du0032u0030u0032u0036uC11Cu002DuC5C5uADF8uB808uC774uB4DCuB41Cu002Du0032u0070u002D-302795280.htmlSOURCE
More news about: Antai Solar
Jun 09, 2026, 08:49 ET Kids Can Earn a "PhD in Poop" at The Poop Museum's New Science Summer Camp!
multiple Gross, Weird, Cool Science programs. Her newest smash hit "Their BUTT does WHAT?!?!" features exploding butts, inflating butts, 3D printer butts and many, many more butts that do quite fabulous things!MEDIA CONTACT:Susie MaguireGrand PoobahThe Poop
More news about: The Poop Museum
Jun 09, 2026, 08:43 ET ResVita Bio Appoints John D. Doux, M.D., M.B.A., to Board of Directors
modality where living, genetically engineered bacteria continuously produce protein therapeutics for skin diseases, today announced the appointment of John D. Doux, M.D., M.B.A., to its Board of Directors. "We are thrilled to welcome John to our Board as ResVita prepares to enter the clinic with RVB-003
More news about: ResVita Bio
Jun 09, 2026, 08:42 ET Journal of a Visionary Reveals the Raw, Unfiltered Truth Behind Building a Meaningful Business
R. Scott Holmes, Collin Jewett, Braxton Kilgo, AliceAnne Loftus, Susan S. Mahaffee, Molly McMillan, Dr. Charleen M. Michel, Kathleen Mitchell, Edith D. Oduraa, Jonathan Probert, Dr. Oliver T. Reid, Karen Lynn Robinson, Jackie Belk Scott, Shari Teigman, Anne Marie Tosse, and Lulu Trevena.Thanks
More news about: Brave Healer Productions
Jun 09, 2026, 08:38 ET Spokbee Inc. Launches Spokbee.ai, an AI-Powered Platform for 3D Product Configurators, Instant Quoting, and Manufacturing Handoff
Spokbee Inc. announced the launch of Spokbee.ai, a new AI-powered platform designed to help manufacturers build AI-powered 3D product configurators, generate instant quotes, and streamline the manufacturing handoff more quickly and efficiently.
More news about: YBI; Spokbee Inc.
Jun 09, 2026, 08:36 ET Kodiak Expands Frozen Breakfast and Snack Lineup with Two New Launches: Turkey Sausage Breakfast Sandwiches and Drizzled Mini Granola Bars
KodiakCakes.com."At Kodiak, we never stop looking for ways to make better-for-you food more delicious and more convenient," said Sonali Dalvi, Head of R&D at Kodiak. "With the launch of our new Turkey Sausage Breakfast Sandwich and Drizzled Minis, we are continuing to prove that convenience doesn't have
More news about: Kodiak
Jun 09, 2026, 08:31 ET THERABODY LANZA CRYOTHERM™ PALM, SU PRIMER DISPOSITIVO DE REGULACIÓN TÉRMICA, CIENTÍFICAMENTE PROBADO PARA REFRESCAR LAS PALMAS DE LAS MANOS Y CONTROLAR EL CALOR EN EL ESCENARIO MÁS IMPORTANTE DEL DEPORTE
sociales.*Resultados de un estudio cruzado aleatorizado con la Universidad del Sur de California y en el que participaron atletas universitarios D1 (n = 21) que realizaron 4 series de press militar hasta el fallo al 85 % en 1RM, con una sola aplicación de CryoTherm™ Palm entre series. Los resultados
More news about: Therabody
Jun 09, 2026, 08:30 ET Quantropi Announces General Availability of Integrated Nokia Solution Delivering Quantum Safe Out‑of‑Band Key Distribution
Digital Quantum Key Distribution (D‑QKD) technology with Nokia's
More news about: Quantropi Inc.
Jun 09, 2026, 08:30 ET Quantropi Announces General Availability of Integrated Nokia Solution Delivering Quantum Safe Out‑of‑Band Key Distribution
Digital Quantum Key Distribution (D‑QKD) technology with Nokia's
More news about: Quantropi Inc.
Jun 09, 2026, 08:23 ET First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody
antibody therapeutics in immunology, oncology and other areas. The Company is building a robust portfolio and differentiated pipeline through internal R&D capability, strategic global collaborations in co-discovery and co-development, and selective acquisitions.Our proprietary antibody technology
More news about: Harbour BioMed
Jun 09, 2026, 08:23 ET Pudu Robotics y Robobee se unen a Denner para desplegar sistemas de limpieza robótica en tiendas suizas
robótica inteligente global que preste servicio a 10.000 millones de personas en todo el mundo.Pudu Robotics ha logrado un desarrollo integral de I+D propio en tecnologías clave, incluyendo algoritmos de navegación, programación de múltiples robots, control de enjambres, controladores de movimiento
More news about: Pudu Robotics
Jun 09, 2026, 08:18 ET THERABODY LANÇA O CRYOTHERM™ PALM, SEU PRIMEIRO DISPOSITIVO DE TERMORREGULAÇÃO DE ALTO DESEMPENHO, UM SISTEMA DE REFRIGERAÇÃO DAS MÃOS COMPROVADO CIENTIFICAMENTE PARA CONTROLAR O CALOR NO MAIOR PALCO DO ESPORTE
próximos jogos.O CryoTherm Palm é o único dispositivo de resfriamento de palma validado em dois estudos controlados: um com atletas da Divisão 1 (D1) da Universidade do Sul da Califórnia focados em treinamento de força e um segundo com jogadores de futebol de elite da IMG Academy realizando esforços
More news about: Therabody
Jun 09, 2026, 08:15 ET Beck Technology Launches DESTINI Cloud, Unifying Preconstruction with an AI-Powered Connected Platform
Integrated 2D and 3D takeoff directly connected to the estimate
More news about: Beck Technology
Jun 09, 2026, 08:14 ET Kelun-Biotech Partner Windward Bio Announces First Patients Dosed in Phase 2 SIRIUS COPD Study of SKB378/WIN378
quarter of 2026.About Kelun-Biotech Kelun-Biotech (6990.HK) is a holding subsidiary of Kelun Pharmaceutical, which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative biological drugs and small molecule drugs. Kelun-Biotech focuses on major
More news about: Kelun-Biotech
Jun 09, 2026, 08:05 ET Unlock Technologies, D2 Asset Management Close $358.5 Million Home Equity Agreement Securitization
monthly payments, refinancing or selling.About D2 Asset ManagementD2 Asset Management, LP is an alternative investment firm specializing in credit and asset-based investing across the capital structure. Founded in 2024, D2 was established to meet the evolving needs of the modern
More news about: Unlock Technologies
Jun 09, 2026, 08:05 ET TalentLMS Speed-to-Skill Report: Work Is Changing Faster Than Companies Can Build Skills
engage and upskill learners. With an interactive, generative AI content creator and a library of 1000+ courses curated by experts, kickstart your L&D program in a flash and deliver transcendent training that sticks. TalentLMS is powered by Epignosis, a leading software house in workplace tech. Its
More news about: TalentLMS
Jun 09, 2026, 08:00 ET HILL'S PET NUTRITION LAUNCHES PREMIERE NUTRITION SUPPORTING KIDNEY FUNCTION PLUS GI AND SKIN SENSITIVITIES
Hill's Prescription Diet k/d + Derm Complete for dogs and k/d + z/d Hydrolyzed for cats are now available via veterinarian recommendationOVERLAND PARK, Kan., June 9, 2026 /PRNewswire/ --
More news about: Hill's Pet Nutrition
Jun 09, 2026, 08:00 ET HL Mando Selected as GM's Supplier of the Year for Six Years in a Row
ceremony in May, held in Austin, Texas, was attended by Head of HL Mando Americas Region Jason (Jae-hyuk) Kim, Sales Director Jake (Jongkoo) Kang, R&D Director Jeff Pontius, and Production Team Leader Eric Slauson.
More news about: HL Group; HL Mando
Jun 09, 2026, 08:00 ET EY 2026 Biotech Beyond Borders Report: A fundamentally strong biotech industry seeks balance amid continued uncertainty
biobucks flow to China while more than 88% of biobucks AI investment is concentrated in R&D, primarily in drug target identification, drug design and clinical trial patient recruitment. In 2026, expanding R&D investments in China and AI models are poised to fuel a wave of innovation.Adapting
More news about: EY